Tag: tavi

NOAC therapy leads to increased risk of ischaemic events following TAVI...

The one-year bleeding risk for patients with atrial fibrillation (AF) who undergo transcatheter aortic valve implantation (TAVI) is the same whether they are receiving...
Cardiac Rhythm news for specialists

First-in-human data demonstrate safety and efficacy of new lead for temporary...

A first-in-human study has shown that a new temporary lead for cardiac pacing (Tempo Lead, BioTrace Medical) is safe and effective for use in...
Cardiac Rhythm news for specialists

FDA clears temporary pacing lead for use during TAVI and other...

BioTrace Medical has received FDA 510(k) clearance for its Tempo Lead, which a press release describes as an innovative temporary pacing lead that has...